[go: up one dir, main page]

WO2002012344A3 - Methods for using 14266, a human g protein-coupled receptor - Google Patents

Methods for using 14266, a human g protein-coupled receptor Download PDF

Info

Publication number
WO2002012344A3
WO2002012344A3 PCT/US2001/024835 US0124835W WO0212344A3 WO 2002012344 A3 WO2002012344 A3 WO 2002012344A3 US 0124835 W US0124835 W US 0124835W WO 0212344 A3 WO0212344 A3 WO 0212344A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
protein
relates
polynucleotides
invention further
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/024835
Other languages
French (fr)
Other versions
WO2002012344A2 (en
Inventor
Nadine S Weich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Priority to EP01957494A priority Critical patent/EP1311546A2/en
Priority to AU2001279232A priority patent/AU2001279232A1/en
Publication of WO2002012344A2 publication Critical patent/WO2002012344A2/en
Publication of WO2002012344A3 publication Critical patent/WO2002012344A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to methods for using a human G protein-coupled receptor (14266) belonging to the family of mammalian G protein-coupled receptors. The invention also relates to methods for using polynucleotides encoding the 14266 receptor. The invention relates to methods for detecting the presence of a 14266 polypeptide of a 14266 polynucleotide and kits comprising reagents for detecting the presence of a 14266 polypeptide or polynucleotide. The invention further relates to methods of modulating the level or activity of a 14266 polypeptide in a cell. The invention further relates to drug-screening methods using the 14266 polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the 14266 polypeptides and polynucleotides. The invention further relates to agonists and antagonists identified by drug screening methods with the 14266 polypeptides and polynucleotides as a target.
PCT/US2001/024835 2000-08-09 2001-08-08 Methods for using 14266, a human g protein-coupled receptor Ceased WO2002012344A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01957494A EP1311546A2 (en) 2000-08-09 2001-08-08 Methods for using 14266, a human g protein-coupled receptor
AU2001279232A AU2001279232A1 (en) 2000-08-09 2001-08-08 Methods for using 14266, a human g protein-coupled receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63439200A 2000-08-09 2000-08-09
US09/634,392 2000-08-09

Publications (2)

Publication Number Publication Date
WO2002012344A2 WO2002012344A2 (en) 2002-02-14
WO2002012344A3 true WO2002012344A3 (en) 2002-10-03

Family

ID=24543583

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/024835 Ceased WO2002012344A2 (en) 2000-08-09 2001-08-08 Methods for using 14266, a human g protein-coupled receptor

Country Status (3)

Country Link
EP (1) EP1311546A2 (en)
AU (1) AU2001279232A1 (en)
WO (1) WO2002012344A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005461A2 (en) * 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 27 (gpr27)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046378A1 (en) * 1998-03-12 1999-09-16 Yamanouchi Pharmaceutical Co., Ltd. Novel g protein-coupled receptor proteins
WO2000028028A1 (en) * 1998-11-06 2000-05-18 Millennium Pharmaceuticals, Inc. G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
WO2000031258A2 (en) * 1998-11-20 2000-06-02 Arena Pharmaceuticals, Inc. Human orphan g protein-coupled receptors
WO2001007482A1 (en) * 1999-07-27 2001-02-01 Smithkline Beecham Corporation Gpr27, a g-protein coupled receptor
WO2001032865A1 (en) * 1999-11-03 2001-05-10 Merck Patent Gmbh Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046378A1 (en) * 1998-03-12 1999-09-16 Yamanouchi Pharmaceutical Co., Ltd. Novel g protein-coupled receptor proteins
EP1067183A1 (en) * 1998-03-12 2001-01-10 Yamanouchi Pharmaceutical Co. Ltd. Novel g protein-coupled receptor proteins
WO2000028028A1 (en) * 1998-11-06 2000-05-18 Millennium Pharmaceuticals, Inc. G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
WO2000031258A2 (en) * 1998-11-20 2000-06-02 Arena Pharmaceuticals, Inc. Human orphan g protein-coupled receptors
WO2001007482A1 (en) * 1999-07-27 2001-02-01 Smithkline Beecham Corporation Gpr27, a g-protein coupled receptor
WO2001032865A1 (en) * 1999-11-03 2001-05-10 Merck Patent Gmbh Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MATSUMOTO M ET AL: "An Evolutionarily Conserved G-Protein coupled Receptor Family, SREB, Expressed in the Central Nervous System", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 272, no. 2, 7 June 2000 (2000-06-07), pages 576 - 582, XP002164712, ISSN: 0006-291X *
O'DOWD B F ET AL: "DISCOVERY OF THREE NOVEL G-PROTEIN-COUPLED RECEPTOR GENES", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 47, no. 2, 15 January 1998 (1998-01-15), pages 310 - 313, XP000863786, ISSN: 0888-7543 *

Also Published As

Publication number Publication date
WO2002012344A2 (en) 2002-02-14
EP1311546A2 (en) 2003-05-21
AU2001279232A1 (en) 2002-02-18

Similar Documents

Publication Publication Date Title
WO2000000610A3 (en) Human signal peptide-containing proteins
WO2002002634A3 (en) Human extracellular matrix and cell adhesion polypeptides
WO2001012662A3 (en) Membrane associated proteins
JPWO2002044362A1 (en) Diabetes treatment screening method
CA2309903A1 (en) Nucleic acid sequences encoding capsaicin receptor
WO2001042288A3 (en) G-protein coupled receptors
ATE360077T1 (en) 22025, A NEW HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE
WO2005001061A3 (en) Polynucleotides encoding novel adiponectin receptor variants
ATE320489T1 (en) GFR-ALPHA3 AND ITS USES
WO2001059117A3 (en) Seven-transmembrane proteins/g-protein coupled receptors
WO2002008260A3 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
WO2004045369A3 (en) Nuclear receptor-based diagnostic, therapeutic, and screening methods
WO2001007612A3 (en) Receptors and associated proteins
EP1560025A3 (en) Specific markers for diabetes
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2001049847A3 (en) 26904, 38911, and 39404, seven-transmembrane proteins/g-protein coupled receptors
WO2004039940A3 (en) Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof
WO2000056891A3 (en) Human transmembrane proteins
DE69428292D1 (en) RECOMBINANT C140 RECEPTOR, ITS AGONISTS AND ANTAGONISTS
WO2002012344A3 (en) Methods for using 14266, a human g protein-coupled receptor
WO2000028032A3 (en) Human cell surface receptor proteins
AU1712200A (en) G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
WO2003047526A3 (en) Cell adhesion and extracellular matrix proteins
WO2005052123A3 (en) Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
CA2060325A1 (en) Polypeptides with a dopaminergic receptor activity; nucleic acids coding for these polypeptides and use of the latter for screening active substances on said polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001957494

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001957494

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP